UNSPSC 51453704: Hycanthone methanesulfonate

This classification denotes an antihelminthic agent with the molecular formula C20H24N2O2S.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 48830NW22A, chemically known as 9h-thioxanthen-9-one, 1-((2-(diethylamino)ethyl)amino)-4-(hydroxymethyl)-, methanesulfonate (1:1), but more generally known as hycanthone methanesulfonate, which bears US NIH Compound Identifier 31764.

European Medicines Agency schedules hycanthone methanesulfonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08057MIG. Most nations, for tariff purposes, schedule hycanthone methanesulfonate under HS 29349990. SMILES: CCN(CC)CCNC1CCC(C2C1C(=O)C3CCCCC3S2)CO.CS(=O)(=O)O.

UNSPSC 51453704 Hycanthone methanesulfonate is a Commodity code that does not reflect the actual work state and local governments are buying under this taxonomy entry. The recent solicitations tagged to this code — naloxone procurement, medical and first aid supplies for fire departments, generic pharmaceuticals through cooperative purchasing, and direct-to-manufacturer prescription programs — involve finished pharmaceuticals, medical devices, and supply-chain arrangements that fall outside the scope of hycanthone methanesulfonate, a parasiticide chemical compound used primarily in research or specialized veterinary applications. The code shows a fundamental mismatch between its nominal product definition and current state and local procurement activity.

The tagged opportunities reflect purchasing by diverse issuing bodies including county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota MMCAP serving Minnesota, Oregon, and other member jurisdictions). Recent activity includes an IFB from Seminole County for naloxone and drug deactivation systems with a July 2026 response date; an ITB from Tampa for 169 line items of medical and first aid supplies with an estimated contract value of $700,000 and a March 2026 response date; an RFI from Texas HHS regarding direct-to-manufacturer pharmacy prescriptions posted in April 2026; and an RFP from MMCAP for generic multi-source pharmaceuticals and OTC products with a March 2026 deadline. The code does not support reliable pursuit under its stated definition — vendors should verify the correct UNSPSC classification before responding to these opportunities.